ইউরোপীয় ইউনিয়ন -
আইসল্যান্ডীয় -
EMA (European Medicines Agency)
buccolam
neuraxpharm pharmaceuticals s.l. - mídazólam - flogaveiki - psycholeptics - meðferð við langvarandi, bráðum krampaköstum hjá ungbörnum, smábörnum, börnum og unglingum (frá þremur mánuðum til yngri en 18 ára). buccolam verður aðeins hægt að nota af foreldrum / forráðamenn þar sjúklingur hefur verið greind til að hafa flogaveiki. fyrir unglinga milli þrjú og sex mánaða aldur, skal meðferð á sjúkrahúsi þar eftirlit er mögulegt og endurlífgun búnaður er í boði.
আইসলণ্ড -
আইসল্যান্ডীয় -
LYFJASTOFNUN (Icelandic Medicines Agency)
midazolam medical valley munnholslausn 2,5 mg
medical valley invest ab - midazolamum hýdróklóríð - munnholslausn - 2,5 mg
আইসলণ্ড -
আইসল্যান্ডীয় -
LYFJASTOFNUN (Icelandic Medicines Agency)
midazolam medical valley munnholslausn 7,5 mg
medical valley invest ab - midazolamum hýdróklóríð - munnholslausn - 7,5 mg
আইসলণ্ড -
আইসল্যান্ডীয় -
LYFJASTOFNUN (Icelandic Medicines Agency)
midazolam accord stungulyf/innrennslislyf, lausn 5 mg/ml
accord healthcare b.v. - midazolamum hýdróklóríð - stungulyf/innrennslislyf, lausn - 5 mg/ml
আইসলণ্ড -
আইসল্যান্ডীয় -
LYFJASTOFNUN (Icelandic Medicines Agency)
midazolam medical valley munnholslausn 5 mg
medical valley invest ab - midazolamum hýdróklóríð - munnholslausn - 5 mg
আইসলণ্ড -
আইসল্যান্ডীয় -
LYFJASTOFNUN (Icelandic Medicines Agency)
midazolam accord stungulyf/innrennslislyf, lausn 1 mg/ml
accord healthcare b.v. - midazolamum hýdróklóríð - stungulyf/innrennslislyf, lausn - 1 mg/ml
আইসলণ্ড -
আইসল্যান্ডীয় -
LYFJASTOFNUN (Icelandic Medicines Agency)
midazolam medical valley munnholslausn 10 mg
medical valley invest ab - midazolamum hýdróklóríð - munnholslausn - 10 mg
ইউরোপীয় ইউনিয়ন -
আইসল্যান্ডীয় -
EMA (European Medicines Agency)
ranivisio
midas pharma gmbh - ranibizumab - wet macular degeneration; macular edema; diabetic retinopathy; diabetes complications - augnlækningar - ranivisio is indicated in adults for:• the treatment of neovascular (wet) age-related macular degeneration (amd)• the treatment of visual impairment due to diabetic macular oedema (dme)• the treatment of proliferative diabetic retinopathy (pdr)• the treatment of visual impairment due to macular oedema secondary to retinal vein occlusion (branch rvo or central rvo)• the treatment of visual impairment due to choroidal neovascularisation (cnv).
আইসলণ্ড -
আইসল্যান্ডীয় -
LYFJASTOFNUN (Icelandic Medicines Agency)
abstral tungurótartafla 800 míkróg
kyowa kirin holdings b.v. - fentanylum cítrat - tungurótartafla - 800 míkróg
আইসলণ্ড -
আইসল্যান্ডীয় -
LYFJASTOFNUN (Icelandic Medicines Agency)
abstral tungurótartafla 600 míkróg
kyowa kirin holdings b.v. - fentanylum cítrat - tungurótartafla - 600 míkróg